Skip to main content

Table 3 Univariate analysis

From: ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations

Variables

Disease free survival

Cancer specific survival

Overall survival

HR

95 % CI

P

HR

95 % CI

P

HR

95 % CI

P

Gender

[male versus female]

1.213

0.59ā€“2.48

0.596

1.152

0.67ā€“1.96

0.602

1.063

0.70ā€“1.60

0.770

Age

[ā‰¤66 versus >66Ā years]

1.709

0.82ā€“3.55

0.151

1.153

0.68ā€“1.94

0.592

1.191

0.79ā€“1.77

0.390

Smoking status

[never versus current/former]

1.478

0.60ā€“1.47

0.395

1.782

0.85 - 3.69

0.121

1.332

0.79ā€“2.23

0.278

Comorbidity

[no versus yes]

1.395

0.65ā€“2.96

0.388

-

-

-

-

-

-

ALK-CNGa

[Disomic/3-7 versusā€‰>ā€‰7]

1.695

0.49ā€“5.77

0.399

1.498

0.62ā€“3.57

0.363

1.598

0.85ā€“2.98

0.141

Disease stage

[I-II versus III]

13.12

4.59ā€“37.4

<0.001

-

-

-

-

-

-

T descriptor

[1ā€“2 versus 3ā€“4]

3.920

1.73ā€“8.86

0.001

-

-

-

-

-

-

N descriptor

[0 versus 1]

4.259

1.79ā€“10.2

0.001

-

-

-

-

-

-

Grading

[1 versus 2 versus 3]

2.128

3.390

0.42ā€“10.6

0.73ā€“15.6

0.357

0.117

-

-

-

-

-

-

Surgery

[yes versus no]

8.425

3.65ā€“19.3

<0.001

-

-

-

-

-

-

Performance Status

[0 versus 1 versus 2ā€“3]

-

-

-

2.358

4.581

1.25ā€“4.42

1.81ā€“11.5

0.007

0.001

1.647

3.864

1.00ā€“2.70

1.98ā€“7.52

0.049

<0.001

Synchronous Metastases

[no versus yes]

-

-

-

1.119

0.15ā€“8.14

0.912

2.335

1.52ā€“3.58

<0.001

Response rate to 1st line

[yes versus no]

-

-

-

-

-

-

2.356

1.31ā€“4.23

0.004

  1. HR hazard ratios, CI confidence intervals, CNG copy number gain
  2. aThe results of the univariate analysis are not significant even categorizing individually the variables [disomic versus 3ā€“7 versusā€‰>ā€‰7]